A review in the Journal of Population Therapeutics and Clinical Pharmacology, 2023 examining the ethics of off-label GLP-1 use notes that unsupervised cosmetic use bypasses the risk screening that regulatory approval was designed to require
As demand for these medications has soared in recent years, periodic shortages prompted companies like Hims & Hers to step into the market with compounded, sometimes cheaper options
Non-oral birth-control options that are unaffected by GLP-1s If youre on tirzepatide, or just tired of building reminders into a busy travel/eating routine, switching to a non-oral method is often the simplest move
Empower Pharmacy Eli Lilly v
Compared to newer GLP-1s, Victoza leads to modest A1C lowering and weight loss
If you're naturally curious about your genetics, the StrateGene Report is a powerful tool to guide your journey